scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1540-8167.2012.02381.X |
P698 | PubMed publication ID | 22953789 |
P50 | author | Michel Haïssaguerre | Q3309895 |
Andrea Natale | Q4755205 | ||
Roberto De Ponti | Q57082589 | ||
Gerhard Hindricks | Q67189332 | ||
Hugh Calkins | Q67190496 | ||
Paulus Kirchhof | Q38326091 | ||
Francis E. Marchlinski | Q39899489 | ||
José Jalife | Q41499141 | ||
Carlo Pappone | Q42289994 | ||
P2093 | author name string | Stuart J Connolly | |
Riccardo Cappato | |||
Antonio Raviele | |||
Atul Verma | |||
Douglas L Packer | |||
Karl H Kuck | |||
James R Edgerton | |||
Ralph Damiano | |||
Stephan Willems | |||
Sakis Themistoclakis | |||
David J Wilber | |||
Hans Kottkamp | |||
John A Camm | |||
Vivek K Reddy | |||
Siew Y Ho | |||
Eric Prystowsky | |||
Shih Ann Chen | |||
Venice Chart | |||
P2860 | cites work | Efficacy and Risk of Atrial Fibrillation Ablation Before 45 Years of Age | Q56607940 |
2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline) | Q56986266 | ||
Acute Pyloric Spasm and Gastric Hypomotility | Q57914325 | ||
Esophageal perforation during left atrial radiofrequency ablation: Is the risk too high? | Q57916018 | ||
Left Atrial Function After Ablation for Paroxysmal Atrial Fibrillation | Q58757461 | ||
Left Atrial-Esophageal Fistula Following Radiofrequency Catheter Ablation of Atrial Fibrillation | Q58757654 | ||
Feasibility of catheter ablation of mitral annular flutter in patients with prior mitral valve surgery | Q58814817 | ||
Antiarrhythmics After Ablation of Atrial Fibrillation (5A Study) | Q58814966 | ||
Increased Intensity of Anticoagulation May Reduce Risk of Thrombus During Atrial Fibrillation Ablation Procedures in Patients with Spontaneous Echo Contrast | Q58815151 | ||
Mechanisms of Organized Left Atrial Tachycardias Occurring After Pulmonary Vein Isolation | Q58815181 | ||
Clinical use of AcuNav diagnostic ultrasound catheter imaging during left heart radiofrequency ablation and transcatheter closure procedures | Q58815210 | ||
Electrical Disconnection of the Coronary Sinus by Radiofrequency Catheter Ablation to Isolate a Trigger of Atrial Fibrillation | Q58865331 | ||
Techniques, Evaluation, and Consequences of Linear Block at the Left Atrial Roof in Paroxysmal Atrial Fibrillation | Q58865408 | ||
Left Atrial Appendage | Q59248784 | ||
Prevention of phrenic nerve injury during epicardial ablation: Comparison of methods for separating the phrenic nerve from the epicardial surface | Q59248796 | ||
Initial experience with the Mesh catheter for pulmonary vein isolation in patients with paroxysmal atrial fibrillation | Q59248804 | ||
Rationale and current perspective for early rhythm control therapy in atrial fibrillation. | Q27692632 | ||
The Cox maze III procedure for atrial fibrillation: long-term efficacy in patients undergoing lone versus concomitant procedures | Q28235445 | ||
Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation | Q28237224 | ||
Video-assisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation | Q28271537 | ||
HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up | Q28305515 | ||
Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins | Q29620720 | ||
The effect of a residual isthmus of surviving tissue on conduction after linear ablation in atrial myocardium | Q30849735 | ||
Left atrial posterior wall thickness in patients with and without atrial fibrillation: data from 298 consecutive autopsies. | Q31147099 | ||
Phrenic nerve injury after catheter ablation: should we worry about this complication? | Q33247971 | ||
Balloon catheter ablation to treat paroxysmal atrial fibrillation: what is the level of pulmonary venous isolation? | Q33322028 | ||
Ablation for longstanding permanent atrial fibrillation: results from a randomized study comparing three different strategies | Q33393194 | ||
Visually-guided balloon catheter ablation of atrial fibrillation: experimental feasibility and first-in-human multicenter clinical outcome | Q33471968 | ||
Chronic atrial fibrillation is a biatrial arrhythmia: data from catheter ablation of chronic atrial fibrillation aiming arrhythmia termination using a sequential ablation approach | Q33508960 | ||
Locating the right phrenic nerve by imaging the right pericardiophrenic artery with computerized tomographic angiography: implications for balloon-based procedures | Q33546944 | ||
Visual balloon-guided point-by-point ablation: reliable, reproducible, and persistent pulmonary vein isolation | Q33588361 | ||
Additional ablation of complex fractionated atrial electrograms after pulmonary vein isolation in patients with atrial fibrillation: a meta-analysis | Q33815028 | ||
Substrate and Trigger Ablation for Reduction of Atrial Fibrillation (STAR AF): a randomized, multicentre, international trial | Q33886896 | ||
Five-year outcomes after segmental pulmonary vein isolation for paroxysmal atrial fibrillation | Q33942897 | ||
Complex fractionated electrograms and AF nests in vagally mediated atrial fibrillation | Q34126357 | ||
Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? | Q34157847 | ||
Fluoroscopy: patient radiation exposure issues | Q34307975 | ||
A new treatment for atrial fibrillation based on spectral analysis to guide the catheter RF-ablation | Q34363929 | ||
Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation | Q34396457 | ||
The Cox maze IV procedure: predictors of late recurrence | Q34558259 | ||
Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association | Q34583344 | ||
Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats | Q34721297 | ||
Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation | Q34723534 | ||
Ablation of permanent AF: adjunctive strategies to pulmonary veins isolation: targeting AF NEST in sinus rhythm and CFAE in AF. | Q34796005 | ||
Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation | Q34979679 | ||
Impact of type of atrial fibrillation and repeat catheter ablation on long-term freedom from atrial fibrillation: results from a multicenter study. | Q43283877 | ||
Incidence and predictors of silent cerebral embolism during pulmonary vein catheter ablation for atrial fibrillation | Q43502754 | ||
Atrial fibrillation ablation: a cost or an investment? | Q43702193 | ||
Minimally invasive pulmonary vein isolation and partial autonomic denervation for surgical treatment of atrial fibrillation | Q43940489 | ||
Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study | Q43984938 | ||
Does catheter ablation cure atrial fibrillation? Single-procedure outcome of drug-refractory atrial fibrillation ablation: a 6-year multicentre experience | Q43993524 | ||
Clinical predictors and outcomes associated with acute return of pulmonary vein conduction during pulmonary vein isolation for treatment of atrial fibrillation | Q44022073 | ||
Image integration increases efficacy of paroxysmal atrial fibrillation catheter ablation: results from the CartoMerge Italian Registry. | Q44050149 | ||
Efficacy, safety, and outcome of atrial fibrillation ablation in septuagenarians | Q44088654 | ||
Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up | Q44119179 | ||
Autonomic innervation and segmental muscular disconnections at the human pulmonary vein-atrial junction: implications for catheter ablation of atrial-pulmonary vein junction | Q44248443 | ||
Antiarrhythmics after ablation of atrial fibrillation (5A Study): six-month follow-up study | Q44272216 | ||
CHADS(2) and CHA(2)DS(2)-VASc scores in the prediction of clinical outcomes in patients with atrial fibrillation after catheter ablation | Q44282049 | ||
Reinduction of atrial fibrillation immediately after termination of the arrhythmia is mediated by late phase 3 early afterdepolarization-induced triggered activity | Q44403583 | ||
Atrial fibrillation originating from persistent left superior vena cava | Q44752432 | ||
A nationwide survey on the prevalence of atrioesophageal fistula after left atrial radiofrequency catheter ablation | Q44786927 | ||
Microbubbles during radiofrequency catheter ablation: composition and formation | Q44910145 | ||
A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate | Q44917498 | ||
Effects of gap geometry on conduction through discontinuous radiofrequency lesions | Q44918694 | ||
Results of a minimally invasive surgical pulmonary vein isolation and ganglionic plexi ablation for atrial fibrillation: single-center experience with 12-month follow-up | Q44950939 | ||
"Dormant" pulmonary vein conduction revealed by adenosine after ostial radiofrequency catheter ablation | Q45055483 | ||
Complete isolation of left atrium surrounding the pulmonary veins: new insights from the double-Lasso technique in paroxysmal atrial fibrillation | Q45091713 | ||
Long-term clinical results of 2 different ablation strategies in patients with paroxysmal and persistent atrial fibrillation | Q45126051 | ||
Long-term outcome of atrial fibrillation ablation: impact and predictors of very late recurrence | Q45166066 | ||
Characterization, mapping, and catheter ablation of recurrent atrial tachycardias after stepwise ablation of long-lasting persistent atrial fibrillation | Q45389191 | ||
Catheter ablation of long-standing persistent atrial fibrillation: a lesson from circumferential pulmonary vein isolation | Q45399156 | ||
Atrial flutter ablation in inducible patients during pulmonary vein atrum isolation: a randomized comparison | Q45760652 | ||
Robotic Navigation in Catheter Ablation for Paroxysmal Atrial Fibrillation: Midterm Efficacy and Predictors of Postablation Arrhythmia Recurrences | Q45859552 | ||
Effectiveness of a strategy to reduce major vascular complications from catheter ablation of atrial fibrillation. | Q45908804 | ||
Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. | Q45999295 | ||
The use of dabigatran immediately after atrial fibrillation ablation. | Q46007747 | ||
Ablation of atrial fibrillation under therapeutic warfarin reduces periprocedural complications: evidence from a meta-analysis | Q46084793 | ||
Clinical outcomes of catheter substrate ablation for high-risk patients with atrial fibrillation | Q46103078 | ||
A randomized assessment of the incremental role of ablation of complex fractionated atrial electrograms after antral pulmonary vein isolation for long-lasting persistent atrial fibrillation. | Q46107704 | ||
Coronary air embolism complicating transseptal radiofrequency ablation of left free-wall accessory pathways | Q46139407 | ||
Impact of a comprehensive safety program on radiation exposure during catheter ablation of atrial fibrillation: a prospective study | Q46261568 | ||
Complications of catheter ablation for atrial fibrillation: incidence and predictors | Q46433037 | ||
Incidence and outcome of femoral vascular complications among 18,165 patients undergoing cardiac catheterisation. | Q46490707 | ||
Triggered firing in pulmonary veins initiated by in vitro autonomic nerve stimulation | Q46515466 | ||
Embolic events and char formation during pulmonary vein isolation in patients with atrial fibrillation: impact of different anticoagulation regimens and importance of intracardiac echo imaging | Q46536846 | ||
Extensive ablation during pulmonary vein antrum isolation has no adverse impact on left atrial function: an echocardiography and cine computed tomography analysis | Q46558753 | ||
Response of atrial fibrillation to pulmonary vein antrum isolation is directly related to resumption and delay of pulmonary vein conduction | Q46630211 | ||
A delayed case of fatal atrioesophageal fistula following radiofrequency ablation for atrial fibrillation | Q46717118 | ||
Long-term follow-up after radiofrequency catheter ablation for atrial fibrillation | Q46744140 | ||
Effect of mitral isthmus block on development of atrial tachycardia following ablation for atrial fibrillation | Q46803555 | ||
Atrial fibrillation ablation in patients with therapeutic international normalized ratio: comparison of strategies of anticoagulation management in the periprocedural period | Q46903146 | ||
Experimental model for paroxysmal atrial fibrillation arising at the pulmonary vein-atrial junctions | Q46916872 | ||
Circumferential pulmonary vein ablation with additional linear ablation results in an increased incidence of left atrial flutter compared with segmental pulmonary vein isolation as an initial approach to ablation of paroxysmal atrial fibrillation | Q46950166 | ||
Circumferential pulmonary-vein ablation for chronic atrial fibrillation | Q46971003 | ||
Effect of radiofrequency catheter ablation for atrial fibrillation on left atrial cavity size | Q47341678 | ||
Successful radiofrequency ablation in patients with previous atrial fibrillation results in a significant decrease in left atrial size | Q47366431 | ||
The magnetic navigation system allows safety and high efficacy for ablation of arrhythmias. | Q35059993 | ||
The Cox-maze IV procedure for lone atrial fibrillation: a single center experience in 100 consecutive patients | Q35095901 | ||
Familial atrial fibrillation is a genetically heterogeneous disorder. | Q35160348 | ||
Transcatheter angioplasty for acquired pulmonary vein stenosis after radiofrequency ablation. | Q35210604 | ||
The cox-maze procedure for lone atrial fibrillation: a single-center experience over 2 decades | Q35784398 | ||
Techniques for curative treatment of atrial fibrillation | Q35989523 | ||
Should atrial fibrillation ablation be considered first-line therapy for some patients? Why atrial fibrillation ablation should be considered first-line therapy for some patients | Q36237973 | ||
Emerging concepts on catheter ablation of atrial fibrillation from the tenth annual Boston Atrial Fibrillation Symposium | Q36262266 | ||
Prevalence and predictors of complications of radiofrequency catheter ablation for atrial fibrillation | Q36318215 | ||
Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias | Q36319444 | ||
Atrial fibrillation ablation: state of the art. | Q36362979 | ||
How to perform encircling ablation of the left atrium | Q36583093 | ||
American College of Cardiology/American Heart Association 2006 update of the clinical competence statement on invasive electrophysiologystudies,catheterablation,andcardioversion: a report of the American College of Cardiology/American Heart Associat | Q36608027 | ||
Case report: Cerebral air embolization in the electrophysiology laboratory during transseptal catheterization: curative treatment of acute left hemiparesis with prompt hyperbaric oxygen therapy | Q36620526 | ||
Mapping and ablation of left atrial tachycardias occurring after atrial fibrillation ablation | Q36751233 | ||
Venice Chart international consensus document on atrial fibrillation ablation. | Q36800522 | ||
Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: a systematic review | Q37117322 | ||
Magnetic and robotic navigation for catheter ablation: "joystick ablation". | Q37184561 | ||
A systematic review of randomized trials comparing radiofrequency ablation with antiarrhythmic medications in patients with atrial fibrillation | Q37262200 | ||
Atrial septopulmonary bundle of the posterior left atrium provides a substrate for atrial fibrillation initiation in a model of vagally mediated pulmonary vein tachycardia of the structurally normal heart | Q37262241 | ||
Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. | Q37300516 | ||
Remote navigation systems in electrophysiology | Q37309969 | ||
Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation | Q37335546 | ||
Cost-effectiveness of radiofrequency catheter ablation for the treatment of atrial fibrillation in the United Kingdom | Q37354613 | ||
Cost-effectiveness of atrial fibrillation catheter ablation | Q37355467 | ||
Balloon catheters for pulmonary vein isolation | Q37366505 | ||
Cost-effectiveness of radiofrequency catheter ablation compared with antiarrhythmic drug therapy for paroxysmal atrial fibrillation | Q37382857 | ||
Localization of left atrial ganglionated plexi in patients with atrial fibrillation | Q37534793 | ||
Systematic review: comparative effectiveness of radiofrequency catheter ablation for atrial fibrillation | Q37542755 | ||
Genetics of familial atrial fibrillation | Q37576796 | ||
Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses | Q37609736 | ||
Transseptal catheterization: considerations and caveats | Q37627343 | ||
Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation. | Q37684527 | ||
Outcomes of long-standing persistent atrial fibrillation ablation: a systematic review | Q37703558 | ||
Meta-analysis of the effect of radiofrequency catheter ablation on left atrial size, volumes and function in patients with atrial fibrillation | Q37733866 | ||
Emergency bypass post percutaneous atrial ablation: a case report | Q37779167 | ||
Correlative Anatomy for the Electrophysiologist, Part II: Cardiac Ganglia, Phrenic Nerve, Coronary Venous System | Q37784250 | ||
The techniques for catheter ablation of paroxysmal and persistent atrial fibrillation: a systematic review | Q37811784 | ||
Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention. | Q37868371 | ||
Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial | Q38376136 | ||
Radiofrequency catheter ablation and antiarrhythmic drug therapy: a prospective, randomized, 4-year follow-up trial: the APAF study | Q38483938 | ||
Improvements in symptoms and quality of life in patients with paroxysmal atrial fibrillation treated with radiofrequency catheter ablation versus antiarrhythmic drugs. | Q38498903 | ||
A prospective, single-center clinical trial of a modified Cox maze procedure with bipolar radiofrequency ablation | Q38516282 | ||
Clinical presentation, investigation, and management of pulmonary vein stenosis complicating ablation for atrial fibrillation | Q39370916 | ||
A novel radiofrequency ablation catheter using contact force sensing: Toccata study | Q39713696 | ||
Catheter ablation of atrial fibrillation: randomized controlled trials and registries, a look back and the view forward. | Q39762638 | ||
The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation | Q39899229 | ||
Clinical predictors and relationship between early and late atrial tachyarrhythmias after pulmonary vein antrum isolation. | Q40115871 | ||
Cost-effectiveness of radiofrequency catheter ablation for atrial fibrillation | Q40315076 | ||
Feasibility study of endocardial mapping of ganglionated plexuses during catheter ablation of atrial fibrillation. | Q40339080 | ||
Temporary esophageal stenting allows healing of esophageal perforations following atrial fibrillation ablation procedures. | Q40480284 | ||
Brief communication: atrial-esophageal fistulas after radiofrequency ablation. | Q40481226 | ||
Pulmonary vein stenosis after radiofrequency ablation of atrial fibrillation: functional characterization, evolution, and influence of the ablation strategy | Q40548867 | ||
Intrapericardial balloon placement for prevention of collateral injury during catheter ablation of the left atrium in a porcine model. | Q41823418 | ||
Damage to the esophagus after atrial fibrillation ablation: Just the tip of the iceberg? High prevalence of mediastinal changes diagnosed by endosonography | Q42651223 | ||
Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio. | Q42662461 | ||
Prevention of atrial fibrillation recurrence with corticosteroids after radiofrequency catheter ablation: a randomized controlled trial | Q42857051 | ||
Loss of pace capture on the ablation line: a new marker for complete radiofrequency lesions to achieve pulmonary vein isolation | Q43149305 | ||
Acute and long-term results of PVI at antrum using a novel high-density mapping catheter without help of 3D electro-anatomic mapping in patients with paroxysmal and chronic atrial fibrillation. | Q43189074 | ||
Radiofrequency ablation of atrial fibrillation under therapeutic international normalized ratio: a safe and efficacious periprocedural anticoagulation strategy | Q43227853 | ||
Atrial fibrillation ablation strategies for paroxysmal patients: randomized comparison between different techniques. | Q43266237 | ||
Radiofrequency puncture of the fossa ovalis for resistant transseptal access | Q43266245 | ||
Minimally invasive surgical release of entrapped mapping catheter in the mitral valve. | Q47432917 | ||
Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3-center study | Q47446761 | ||
Efficacy of pulmonary vein isolation by cryoballoon ablation in patients with paroxysmal atrial fibrillation | Q47660498 | ||
Atrial arrhythmias after single-ring isolation of the posterior left atrium and pulmonary veins for atrial fibrillation: mechanisms and management | Q47675589 | ||
Catheter ablation of paroxysmal atrial fibrillation initiated by non-pulmonary vein ectopy | Q47810712 | ||
Transseptal puncture for catheter ablation of atrial fibrillation after device closure of patent foramen ovale | Q47880800 | ||
Comparison of stent versus balloon angioplasty for pulmonary vein stenosis complicating pulmonary vein isolation | Q47903887 | ||
What is the real atrial fibrillation burden after catheter ablation of atrial fibrillation? A prospective rhythm analysis in pacemaker patients with continuous atrial monitoring | Q47923313 | ||
Deep sedation for catheter ablation of atrial fibrillation: a prospective study in 650 consecutive patients | Q48253618 | ||
General anesthesia reduces the prevalence of pulmonary vein reconnection during repeat ablation when compared with conscious sedation: results from a randomized study | Q48313775 | ||
Low efficacy of atrial fibrillation ablation in severe obstructive sleep apnoea patients. | Q48357194 | ||
Atrial tachycardias adjacent to the phrenic nerve: recognition, potential problems, and solutions | Q48417058 | ||
Selective atrial vagal denervation guided by evoked vagal reflex to treat patients with paroxysmal atrial fibrillation | Q48492511 | ||
A novel mesh electrode catheter for mapping and radiofrequency delivery at the left atrium-pulmonary vein junction: a single-catheter approach to pulmonary vein antrum isolation | Q48616381 | ||
Long-term clinical outcome following pulmonary vein isolation with high-intensity focused ultrasound balloon catheters in patients with paroxysmal atrial fibrillation | Q50247369 | ||
Pulmonary vein isolation with high-intensity focused ultrasound: results from the HIFU 12F study | Q50247755 | ||
Gross and microscopic anatomy of the human intrinsic cardiac nervous system. | Q50531123 | ||
Occupational hazards of interventional cardiologists: prevalence of orthopedic health problems in contemporary practice. | Q50752249 | ||
Incidence of atrial arrhythmias detected by permanent pacemakers (PPM) post-pulmonary vein antrum isolation (PVAI) for atrial fibrillation (AF): correlation with symptomatic recurrence. | Q51027235 | ||
Cost comparison of catheter ablation and medical therapy in atrial fibrillation. | Q51104318 | ||
Patient and staff radiation dosimetry during cardiac electrophysiology studies and catheter ablation procedures: a comprehensive analysis. | Q51204028 | ||
Comparison of electrode cooling between internal and open irrigation in radiofrequency ablation lesion depth and incidence of thrombus and steam pop. | Q51298174 | ||
Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. | Q51321662 | ||
Acute occlusion of the left circumflex coronary artery during mitral isthmus linear ablation. | Q51347569 | ||
Very low risk of thromboembolic events in patients undergoing successful catheter ablation of atrial fibrillation with a CHADS2 score ≤3: a long-term outcome study. | Q51426209 | ||
Complications arising from catheter ablation of atrial fibrillation: temporal trends and predictors. | Q51433465 | ||
Differentiating macroreentrant from focal atrial tachycardias occurred after circumferential pulmonary vein isolation. | Q51613133 | ||
Catheter ablation of atrial fibrillation using remote magnetic catheter navigation: a case-control study. | Q51625893 | ||
Contact sensing provides a highly accurate means to titrate radiofrequency ablation lesion depth. | Q51629914 | ||
Efficacy of adjuvant anterior left atrial ablation during intracardiac echocardiography-guided pulmonary vein antrum isolation for atrial fibrillation. | Q51763512 | ||
Long-term outcome after successful catheter ablation of atrial fibrillation. | Q51777063 | ||
Ablation of atrial fibrillation utilizing robotic catheter navigation in comparison to manual navigation and ablation: single-center experience. | Q51805454 | ||
Core curriculum for the heart rhythm specialist: executive summary. | Q51927510 | ||
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiolog | Q51935524 | ||
Asymptomatic recurrences of atrial fibrillation after pulmonary vein isolation. | Q51939103 | ||
Catheter entrapment in a pulmonary vein: a unique complication of pulmonary vein isolation. | Q52602605 | ||
Effect of therapeutic INR on activated clotting times, heparin dosage, and bleeding risk during ablation of atrial fibrillation. | Q53168576 | ||
Visualization of multiple catheters with electroanatomical mapping reduces X-ray exposure during atrial fibrillation ablation. | Q53237006 | ||
Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. | Q53295361 | ||
Catheter ablation for atrial fibrillation in congestive heart failure. | Q53317630 | ||
Ablation of persistent atrial fibrillation using multielectrode catheters and duty-cycled radiofrequency energy. | Q53495255 | ||
Integrated electroanatomic mapping with three-dimensional computed tomographic images for real-time guided ablations. | Q53557077 | ||
Effect of left atrial circumferential ablation for atrial fibrillation on left atrial transport function. | Q53569606 | ||
Multislice computed tomography versus intracardiac echocardiography to evaluate the pulmonary veins before radiofrequency catheter ablation of atrial fibrillation: a head-to-head comparison. | Q53596363 | ||
Electrophysiological breakthroughs from the left atrium to the pulmonary veins. | Q54030199 | ||
Efficacy and safety of septal and left-atrial linear ablation for atrial fibrillation. | Q54071987 | ||
Clinical significance of early recurrences of atrial fibrillation after pulmonary vein isolation. | Q54329527 | ||
A tailored approach to catheter ablation of paroxysmal atrial fibrillation. | Q54655565 | ||
Thoracoscopic Video-Assisted Pulmonary Vein Antrum Isolation, Ganglionated Plexus Ablation, and Periprocedural Confirmation of Ablation Lesions: First Results of a Hybrid Surgical-Electrophysiological Approach for Atrial Fibrillation | Q54952180 | ||
P433 | issue | 8 | |
P921 | main subject | Atrial Fibrillation | Q815819 |
P304 | page(s) | 890-923 | |
P577 | publication date | 2012-08-01 | |
P1433 | published in | Journal of Cardiovascular Electrophysiology | Q4736917 |
P1476 | title | Venice Chart international consensus document on atrial fibrillation ablation: 2011 update | |
P478 | volume | 23 |
Q44542828 | A practical criterion for the rapid detection of single-loop and double-loop reentry tachycardias |
Q37253651 | Adequate Initial Heparin Dosage for Atrial Fibrillation Ablation in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants |
Q58645594 | Atrial fibrillation |
Q38764309 | Automated verification of pulmonary vein isolation in radiofrequency- and cryoballoon-guided ablation. |
Q38606213 | Catheter ablation for atrial fibrillation: results from the first European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA) Part II. |
Q46203145 | Circles and lines: are we opening the Pandora's box of non-paroxysmal atrial fibrillation ablation? |
Q42143598 | Complete Isolation of the Left Atrial Posterior Wall (Box Lesion) to Treat Longstanding Persistent Atrial Fibrillation |
Q37469075 | Contact Force Assessment In Catheter Ablation Of Atrial Fibrillation |
Q48511350 | Differences in the atrial electrophysiological properties between vagal and sympathetic types of atrial fibrillation |
Q35950566 | EFFICAS II: optimization of catheter contact force improves outcome of pulmonary vein isolation for paroxysmal atrial fibrillation |
Q40834168 | Effect of Different Ablation Settings on Acute Complications Using the Novel Irrigated Multipolar Radiofrequency Ablation Catheter (nMARQ). |
Q54543257 | Electrophysiological Evaluation of Pulmonary Vein Isolation. |
Q38635568 | Evolving cardiovascular uses of direct-acting oral anticoagulants: a paradigm shift on the horizon? |
Q44786486 | Excluding the presence of left atrial thrombus before pulmonary vein isolation. |
Q37115519 | How To Follow Atrial Fibrillation Ablation Patients? |
Q45230998 | Impact of radiofrequency characteristics on acute pulmonary vein reconnection and clinical outcome after PVAC ablation |
Q36057957 | Influence of Clinical Parameters and Anticoagulation on Intraprocedural Cerebral Microembolic Signals during Pulmonary Vein Isolation |
Q45839506 | Left atrial sphericity: a new method to assess atrial remodeling. Impact on the outcome of atrial fibrillation ablation. |
Q47975450 | Left atrial ejection force predicts the outcome after catheter ablation for paroxysmal atrial fibrillation |
Q37468795 | Lone Atrial Fibrillation: Risk Factors, Triggers And Ablation Techniques |
Q43156719 | Long-term clinical outcome and risk of catheter ablation in elderly with non-paroxysmal atrial fibrillation |
Q44427484 | Long-term efficacy and safety of two different rhythm control strategies in elderly patients with symptomatic persistent atrial fibrillation |
Q37637902 | Loop Recorder Detected High Rate of Atrial Fibrillation Recurrence after a Single Balloon- or Basket-Based Ablation of Paroxysmal Atrial Fibrillation: Results of the MACPAF Study |
Q38239163 | Major complications of cryoballoon catheter ablation for atrial fibrillation and their management |
Q40891224 | Oral anticoagulant therapy for stroke prevention in patients with atrial fibrillation undergoing ablation: results from the First European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA). |
Q34260267 | Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban |
Q46000086 | Prevention of periprocedural ischemic stroke and management of hemorrhagic complications in atrial fibrillation ablation under continuous warfarin administration. |
Q38217126 | Prospective European survey on atrial fibrillation ablation: clinical characteristics of patients and ablation strategies used in different countries |
Q40378922 | Rationale and design of the ODIn-AF Trial: randomized evaluation of the prevention of silent cerebral thromboembolism by oral anticoagulation with dabigatran after pulmonary vein isolation for atrial fibrillation |
Q46498741 | Ridge-related reentry: a variant of perimitral atrial tachycardia |
Q30490526 | Safety and Efficacy of Under-dosing Non-vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Catheter Ablation for Atrial Fibrillation |
Q58804303 | The Impact of Advances in Atrial Fibrillation Ablation Devices on the Incidence and Prevention of Complications |
Q50175256 | Updated national multicenter registry on procedural safety of catheter ablation for atrial fibrillation. |
Q39236932 | What Is the Appropriate Lesion Set for Ablation in Patients with Persistent Atrial Fibrillation? |
Q43753124 | Which is the best approach for ablation of long-standing persistent atrial fibrillation? |
Q40934452 | Who is the operator, that is the question: a multicentre study of catheter ablation of atrial fibrillation |
Q86645996 | [Pre-interventional, peri-interventional and post-interventional anticoagulation in the setting of catheter ablation for atrial fibrillation : current practice and practical approach] |
Search more.